» Authors » Samuel Paul Costello

Samuel Paul Costello

Explore the profile of Samuel Paul Costello including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 355
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lopetuso L, Deleu S, Puca P, Abreu M, Armuzzi A, Barbara G, et al.
Inflamm Bowel Dis . 2025 Feb; PMID: 39932857
Background: Fecal microbiota transplantation (FMT) is emerging as a potential treatment modality for individuals living with inflammatory bowel disease (IBD). Despite its promise, the effectiveness of FMT for treating IBD,...
2.
Lopetuso L, Deleu S, Godny L, Petito V, Puca P, Facciotti F, et al.
Gut . 2023 Jun; 72(9):1642-1650. PMID: 37339849
Background: Several randomised clinical trials (RCTs) performing faecal microbiota transplantation (FMT) for the management of inflammatory bowel disease (IBD), particularly for ulcerative colitis, have recently been published, but with major...
3.
Costello S, Day A, Yao C, Bryant R
BMJ Case Rep . 2020 Aug; 13(8). PMID: 32843418
A 19-year-old man presented with acute severe ulcerative colitis. He was taking azathioprine (therapeutic metabolites) and sulphasalazine as well as infliximab with a therapeutic drug level. On day 3 of...
4.
Ianiro G, Mullish B, Kelly C, Kassam Z, Kuijper E, Ng S, et al.
Gut . 2020 Jul; 69(9):1555-1563. PMID: 32620549
The COVID-19 pandemic has led to an exponential increase in SARS-CoV-2 infections and associated deaths, and represents a significant challenge to healthcare professionals and facilities. Individual countries have taken several...
5.
Cammarota G, Ianiro G, Kelly C, Mullish B, Allegretti J, Kassam Z, et al.
Gut . 2019 Sep; 68(12):2111-2121. PMID: 31563878
Although faecal microbiota transplantation (FMT) has a well-established role in the treatment of recurrent infection (CDI), its widespread dissemination is limited by several obstacles, including lack of dedicated centres, difficulties...
6.
Bryant R, Schultz C, Ooi S, Goess C, Costello S, Vincent A, et al.
Inflamm Bowel Dis . 2018 Nov; 25(6):e62-e63. PMID: 30380064
No abstract available.
7.
Bryant R, Schultz C, Ooi S, Goess C, Costello S, Vincent A, et al.
Inflamm Bowel Dis . 2018 Sep; 25(3):592-600. PMID: 30215805
Background: Visceral adipose tissue (VAT) has been proposed to play a pathogenic role in Crohn's disease (CD); however, prospective clinical data are lacking. The aim was to evaluate whether VAT,...
8.
Bryant R, Schultz C, Ooi S, Goess C, Costello S, Vincent A, et al.
Nutrients . 2018 Sep; 10(9). PMID: 30200405
Background: Rising rates of obesity have been reported in patients with inflammatory bowel disease (IBD); however, prospective data is lacking. The aim of this study is to prospectively evaluate body...